ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance

ANI Pharma (ANIP) Tops Q1 EPS by 25c, Revenues Beat; Reaffirms FY19 Revenue Outlook

May 9, 2019 8:33 AM EDT

ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $1.30, $0.25 better than the analyst estimate of $1.05. Revenue for the quarter came in at $52.9 million versus the consensus estimate of $50.57 million.

Net revenues of $52.9 million, an increase of 14% versus 2018GAAP net income of $0.4 million and diluted GAAP earnings per share of... More